Prime Medicine, Inc.
PRME· Nasdaq
Prime Medicine, Inc.
- Last sale
- Oct 1, 2026 · -1.80%
- Market cap
- $543.22M
- 181.38M shares
- Filings
- 298
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,632,000 | reported | |
| FY 2024 | 2024-12-31 | $2,983,000 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $5,210,000 | reported |
Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR
